Skip to main content

Advertisement

Table 2 Functional parameters

From: Pilot safety study of intrabronchial instillation of bone marrow-derived mononuclear cells in patients with silicosis

  Day 0 Day 7 Day 30 Day 60 Day 180 Day 360
FVC (%) 88.0 ± 15.1 86.3 ± 15.5 87.0 ± 17.2 86.1 ± 14.1 83.8 ± 14.5 88.0 ± 22.8
FEV1 (%) 58.7 ± 6.7 56.9 ± 5.4 57.9 ± 5.6 57.6 ± 4.8 55.6 ± 6.6 55.5 ± 7.2
TLC (%) 87.1 ± 17.3 87.5 ± 18.0 86.9 ± 23.0 86.3 ± 18.7 87.8 ± 18.4 84.5 ± 20.5
Dlco (%) 60.0 ± 16.4 60.2 ± 16.5 55.8 ± 17.9 58.5 ± 14.3 56.0 ± 17.0 57.5 ± 5.0
  1. Data presented as mean ± standard deviation of 5 silicotic patients
  2. FEV 1 Forced expiratory volume in 1 s, FCV Forced vital capacity, TLC Total lung capacity, TLC Total lung capacity, Dlco Diffusing capacity of the lung for carbon monoxide